Integration of Novel Antibody–Drug Conjugates in Advanced HER2-Low, Hormone Receptor–Positive, and Triple-Negative Breast Cancer

Content Format:

PDF

Date:

Nov 13, 2024

Credit Type:

--

Credits:

--
Real-world Perspectives on Novel HER2-Targeted and TROP-2–Directed Therapies in Advanced Breast Cancer

Content Format:

Podcast Episodes

Date:

Mar 20, 2024

Credit Type:

AMA

Credits:

0.75